Two Approaches to Routine HIV Testing in a Hospital Emergency Department
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT00502944|
Recruitment Status : Completed
First Posted : July 18, 2007
Results First Posted : July 13, 2012
Last Update Posted : July 19, 2012
- Study Details
- Tabular View
- Study Results
- How to Read a Study Record
|Condition or disease||Intervention/treatment||Phase|
|HIV Infections||Behavioral: Counselor-based HIV screening Behavioral: Emergency staff member-based HIV screening||Not Applicable|
About 25% of HIV infected people do not know that they are infected. These people lack medical care that could prolong their lives and access to counseling services that could prevent further spread of HIV. With so many people unaware of their HIV status, there is a clear need for more readily available HIV counseling, testing, and referral services throughout the United States. The Centers for Disease Control and Prevention (CDC) recommends routine HIV testing in U.S. hospitals in which HIV infected patients make up at least 1% of the total patient population for that hospital. However, routine HIV testing in such hospitals is rarely carried out, which might be because the CDC has not specified who should perform routine HIV testing. The purpose of this study is to compare the effectiveness of two different approaches to providing routine HIV counseling, testing, and referral services in an urban hospital emergency department setting. One approach will be led by an HIV counselor, and the other approach will be led by an emergency department staff member. For both approaches, the study will evaluate to what extent patients accept HIV testing, how well follow-up care is established, and the cost-effectiveness of the approach.
Participants in this study will include adults who visit Brigham and Women's Hospital emergency department in Boston, Massachusetts. Participants will be randomly assigned to a counselor versus provider and will be asked to fill out a questionnaire while waiting in the emergency room. The questionnaire will be anonymous. Participants will then be offered an oral rapid HIV test. Test results will be available in about 20 minutes and will be provided to participants by either their assigned HIV counselor. Participants who test positive for HIV will be offered a more definitive blood test to confirm HIV infection. The blood test results will be available 2 weeks from testing, and participants must return to the hospital to get their test results. Participants who test positive for HIV will be offered counseling support and referral services by either their assigned HIV counselor or emergency department staff member. Follow-up care appointments will also be initiated at this time. For participants who test positive for HIV, the study will last about 6 months. There will be no follow-up visits for participants who do not test positive for HIV during their emergency room visit.
|Study Type :||Interventional (Clinical Trial)|
|Actual Enrollment :||4855 participants|
|Intervention Model:||Parallel Assignment|
|Masking:||None (Open Label)|
|Official Title:||Optimizing Strategies for Universal HIV Testing (The USHER Trial)|
|Study Start Date :||February 2007|
|Actual Primary Completion Date :||July 2008|
|Actual Study Completion Date :||July 2008|
|Experimental: Counselor-based HIV screening||
Behavioral: Counselor-based HIV screening
Participants will undergo oral HIV screening by HIV counselor and, if positive, further study visits for up to 6 months
|Active Comparator: Emergency staff member-based HIV screening||
Behavioral: Emergency staff member-based HIV screening
Participants will undergo oral HIV screening by emergency staff member and, if positive, further study visits for up to 6 months
- Linkage to Care of Newly Diagnosed HIV Infected Participants [ Time Frame: Assessed within 8 weeks after receipt of reactive rapid HIV test results ]We define linkage to care as attendance at a first HIV clinic appointment where the following 3 events occur: 1) introduction to an HIV care primary provider; 2) receipt of confirmatory Western Blot HIV test results; and 3) phlebotomy for CD4 cell count and HIV RNA level.
- Overall Rapid HIV Testing Rate [ Time Frame: Assess on day subject enrolled into the study ]We defined the overall rapid HIV testing rate as the number of participants tested for HIV using the rapid test among those randomized to potentially be tested in each arm.
- Test Offer Rate [ Time Frame: Assess on day subject enrolled into the study ]The offer rate of the HIV test was defined as the proportion of enrolled study participants who were actually offered a test.
- Test Acceptance Rate [ Time Frame: Assess on day subject enrolled into the study ]Acceptance of the HIV test was defined as the proportion of study participants who received the HIV test among those offered the test.
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
|Ages Eligible for Study:||18 Years and older (Adult, Older Adult)|
|Sexes Eligible for Study:||All|
|Accepts Healthy Volunteers:||No|
- Waiting to receive care in the Brigham and Women's Hospital emergency room
- English- or Spanish-speaking
- Enters the emergency room when an HIV counselor is available
- An estimated severity index score of 1 or 2 who have mechanical ventilation or are not deemed alert, awake, and oriented to person, place and time by the triage nurse
- HIV infected
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00502944
|United States, Massachusetts|
|Brigham and Women's Hospital|
|Boston, Massachusetts, United States, 02115|
|Principal Investigator:||Rochelle P. Walensky, MD, MPH||Massachusetts General Hospital|
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
|Responsible Party:||Rochelle Walensky, Associate Professor, Massachusetts General Hospital|
|Other Study ID Numbers:||
R01MH073445 ( U.S. NIH Grant/Contract )
R01MH073445 ( U.S. NIH Grant/Contract )
|First Posted:||July 18, 2007 Key Record Dates|
|Results First Posted:||July 13, 2012|
|Last Update Posted:||July 19, 2012|
|Last Verified:||July 2012|
Sexually Transmitted Diseases, Viral
Sexually Transmitted Diseases
RNA Virus Infections
Immunologic Deficiency Syndromes
Immune System Diseases